Athanasios Kotsakis Selected Research

human telomerase reverse transcriptase p572Y

4/2021	Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC.
1/2020	Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
2/2012	Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Athanasios Kotsakis Research Topics

Disease

30	Neoplasms (Cancer) 03/2022 - 01/2007
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 05/2006
12	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2006
10	Circulating Neoplastic Cells 10/2021 - 10/2009
6	Neutropenia 06/2016 - 01/2007
4	Disease Progression 01/2019 - 12/2010
3	Lung Neoplasms (Lung Cancer) 09/2020 - 01/2009
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 05/2007
3	Adenocarcinoma 11/2018 - 03/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 07/2010
2	Ovarian Neoplasms (Ovarian Cancer) 06/2019 - 01/2008
2	Atrial Fibrillation 01/2018 - 03/2006
2	Carcinoma (Carcinomatosis) 01/2018 - 03/2012
2	Febrile Neutropenia 06/2016 - 08/2011
2	Infections 06/2016 - 12/2010
2	Thrombocytopenia (Thrombopenia) 08/2013 - 12/2010
1	Cardio-Renal Syndrome 06/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Thrombosis (Thrombus) 10/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2020
1	Arthritis (Polyarthritis) 09/2020
1	Ovarian Epithelial Carcinoma 06/2019
1	Inflammation (Inflammations) 04/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 12/2016

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2010
9	Gemcitabine FDA Link 06/2019 - 01/2006
9	Docetaxel (Taxotere)FDA Link 11/2018 - 01/2006
6	PlatinumIBA 01/2019 - 01/2008
5	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 05/2006
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2010
4	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2007
4	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019 - 05/2006
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2009 - 01/2007
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 05/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2009
3	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2010
3	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2019
3	human telomerase reverse transcriptase p572YIBA 04/2021 - 02/2012
3	human ERBB2 proteinIBA 04/2021 - 01/2019
3	Everolimus FDA Link 01/2021 - 12/2010
3	Hormones (Hormone)IBA 01/2021 - 01/2017
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 11/2011
3	Fluorouracil (Carac)FDA LinkGeneric 11/2018 - 05/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 03/2012
3	Carboplatin (JM8)FDA LinkGeneric 11/2016 - 11/2010
3	Peptides (Polypeptides)IBA 10/2014 - 11/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2011 - 01/2007
2	osimertinibIBA 03/2022 - 01/2021
2	Taxoids (Taxanes)IBA 01/2022 - 01/2020
2	LigandsIBA 01/2022 - 01/2019
2	Cancer VaccinesIBA 04/2021 - 01/2020
2	VaccinesIBA 04/2021 - 02/2012
2	taxaneIBA 01/2020 - 01/2018
2	Topotecan (Hycamtin)FDA LinkGeneric 06/2019 - 07/2010
2	Panitumumab (Vectibix)FDA Link 01/2019 - 11/2018
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 07/2010
2	Leucovorin (Folinic Acid)FDA Link 11/2018 - 05/2007
2	TOR Serine-Threonine KinasesIBA 12/2016 - 12/2010
2	CrizotinibIBA 11/2016 - 09/2013
2	Anaplastic Lymphoma KinaseIBA 11/2016 - 09/2013
2	Pemetrexed (MTA)FDA Link 08/2013 - 08/2011
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021
1	Fondaparinux (Arixtra)FDA Link 10/2021
1	AnticoagulantsIBA 10/2021
1	Protein Isoforms (Isoforms)IBA 04/2021
1	Granzymes (Granzyme)IBA 04/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 09/2020
1	pembrolizumabIBA 09/2020
1	AntigensIBA 01/2020
1	cabazitaxel FDA Link 01/2020
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2019
1	Formaldehyde (Formol)FDA Link 05/2019
1	ParaffinIBA 05/2019
1	afliberceptIBA 01/2019
1	AdiponectinIBA 01/2018
1	AntibodiesIBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	VimentinIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	pazopanib FDA Link 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Circulating Tumor DNAIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2016

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 01/2022 - 01/2006
8	Therapeutics 01/2022 - 01/2015
7	Immunotherapy 11/2021 - 11/2011
4	Salvage Therapy 01/2021 - 01/2006
2	Subcutaneous Injections 02/2012 - 11/2011
1	Adjuvant Chemotherapy 01/2022
1	Maintenance Chemotherapy 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 06/2019
1	Metastasectomy 11/2018
1	Contraindications 06/2016